期刊文献+

BRCA1抑制黄体酮刺激乳腺癌细胞增殖和迁移 被引量:4

BRCA1 inhibits progesterone-induced proliferation and migration of breast cancer cells
下载PDF
导出
摘要 目的研究BRCA1是否可以调节黄体酮刺激乳腺癌细胞增殖和迁移。方法乳腺癌细胞MCF-7和T-47D转染质粒过表达BRCA1或转染相应空质粒作对照,并以黄体酮刺激乳腺癌细胞,观察过表达BRCA1对黄体酮刺激乳腺癌细胞增殖和迁移的影响;MCF-7细胞转染siRNA敲低BRCA1或转染杂乱siRNA作为对照,并加黄体酮刺激乳腺癌细胞,观察敲低BRCA1对黄体酮刺激乳腺癌细胞增殖和迁移的影响;用MTT实验结果计算细胞增殖率,用"划痕愈合实验"结果计算细胞迁移率。结果黄体酮刺激并转染空质粒对照组或过表达BRCA1组:细胞增殖率,MCF-7细胞分别是(114.4±6.0)%和(82.1±3.2)%,T47-D细胞分别是(111.3±4.3)%和(84.2±3.5)%,两组间细胞增殖率差异均有统计学意义(P<0.05);细胞迁移率,MCF-7细胞分别是55.9%和15.8%,T-47D分别是44.83%和10.43%。加黄体酮刺激并转染杂乱siRNA或BRCA1siRNA MCF-7:细胞増殖率分别是(114.4±3.05)%和(125.3±4.0)%,两组间差异有统计学意义(P<0.05);细胞迁移率分别是39.2%和69.08%。黄体酮受体拮抗剂RU486可以拮抗敲低BRCA1增强黄体酮促进乳腺癌细胞增殖和迁移。结论散发性乳腺癌可能因其BRCA1低表达而使黄体酮对乳腺癌细胞的增殖和迁移作用增强。 Objective To study the effect of BRCA1 in regulating the proliferation and migration of breast cancer ceils stimulated by progesterone. Methods Breast cancer MCF-7 and T-47D cell were transfected with a vector containing the coding sequence of BRCA1 (pFlag-CMV2-BRCA1 wt) to induce BRCA1 overexpression or with the empty vector (control). The cells were then stimulated with progesterone, and the cell proliferation and migration were observed using MTT assay and wound healing assay, respectively. The proliferation and migration of MCF-7 cells were also observed following transfection with a small interfering RNA (siRNA) for BRCA1 knockdown or with a scrambled siRNA prior to progesterone stimulation. Results Transfection with the empty vector and with pFlag-CMV2-BRCA1 wt prior to progesterone stimulation caused significantly different proliferation rates in MCF-7 cells [(114.4±6.0)% vs (82.1±3.2)%, P〈0.05] and in T-47D cells [(111.3±4.3)% vs (84.2±3.5)%, P〈0.05], resulting also in significantly different cell migration rates (55.9% vs 15.8% in MCF-7 cells and 44.83% vs 10.43% in T-47D cells). Compared to the scrambled siRNA, BRCA1 siRNA transfection prior to progesterone stimulation significantly increased the proliferation rates [(114.4±3.05)% vs (125.3±4.0)%, P〈0.05] and migration rate (39.2% vs 69.08%) of MCF-7 cells. The progesterone antagonist RU468 could antagonize the effects of BRCA1 knockdown in enhancing progesterone-stimulated MCF-7 cell proliferation and migration. Conclusions A decreased BRCA1 expression can enhance progesterone-stimulated tumor cell proliferation and migration in sporadic breast cancer.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第8期1105-1110,共6页 Journal of Southern Medical University
基金 国家自然科学基金(30470673 81071810)~~
关键词 BRCA1 黄体酮受体 细胞增殖 细胞迁移 BRCA1, progesterone receptor cell proliferation cell migration
  • 相关文献

参考文献24

  • 1Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCAI and BRCA2 genes in breast cancer families[J]. Am J Hum Genet, 1998, 62(3): 676-89. 被引量:1
  • 2Thompson ME, Jensen RA, Obermiller PS, et al. Decreased expression of BRCAI accelerates growth and is often present during sporadic breast cancer progression [J]. Nat Genet, 1995, 9 (4): 444-50. 被引量:1
  • 3Dobrovic A, Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer[J]. Cancer Res, 1997, 57: 3347-50. 被引量:1
  • 4Mullah PB, Quinn JE, Harkin DE The role of BRCA1 in transcriptional regulation and cell cycle control [J]. Oncogene, 2006, 25(43): 5854-63. 被引量:1
  • 5Fan S, Wang J, Yuan R, et al. BRCA1 inhibition of estrogen receptor signaling in transfected cells[J]. Science, 1999, 284(5418): 1354-6. 被引量:1
  • 6Maor SB, Abramovitch S, Erdos MR, et al. BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Spl [J]. Mol Genet Metab, 2000, 69(2): 130-6. 被引量:1
  • 7Burga LN, Hu H, Juvekar A, et al. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCAl-mutant mice[J]. Breast Cancer Res, 2011, 13(2): R30. 被引量:1
  • 8Aprelikova ON, Fang BS, Meissner EG, et al. BRCAl-associated growth arrest is RB-dependent[J]. Proc Natl Acad Sci USA 1999, 96 (21): 11866-71. 被引量:1
  • 9Williamson EA, Dadmanesh F, Koeffler HP. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kipl) [J]. Oncogene, 2002, 21 (2): 3199-206. 被引量:1
  • 10Seery LT, Knowlden JM, Gee JM, et al. BRCA1 expression levels predict distant metastasis of sporadic breast cancers[J]. Int J Cancer, 1999, 84(5): 258-62. 被引量:1

二级参考文献43

  • 1Liang Y, Hyder SM. Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects [Jl. Endocrinology, 2005, 146(8): 3632-41. 被引量:1
  • 2Liang Y, Besch-Williford C, Brekken RA, et al. Progestin-dependent progression of human breast tumor xenogratts: a novel model for evaluating antitumor therapeutics [J]. Cancer Res, 2007, 67 (20): 9929-36. 被引量:1
  • 3Alkhalaf M, ElMowafy A, Karam S. Growth inhibition of MCF-7 human breast cancer cells by progesterone is associated with cell differentiation and phosphorylation of Akt protein [ J ]. Eur J Cancer Prev, 2002, 11(5): 481-8. 被引量:1
  • 4Caldon CE, Lee CS, Sutherland RL, et al. Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation [ J ]. Oncogene, 2008, 27(1): 126-38. 被引量:1
  • 5Gizard F, Robillard R, Gervois P, et al. Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kipl gene [J]. FEBS Lett, 2005, 579(25): 5535-41. 被引量:1
  • 6Groshong SD, Owen GI, Grimison B, et al. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin- dependent kinase inhibitors, p21 and p27 (Kipl) [J]. Mol Endocrinol, 1997, 11(11): 1593-607. 被引量:1
  • 7Hissom JR, Moore MR. Progestin effects on growth in the human breast cancer cell line T-47D-possible therapeutic implications [J ]. Biochem Biophys Res Commun, 1987, 145(2): 706-11. 被引量:1
  • 8Musgrove EA, Lee CS, Sutherland RL. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-los, and c-myc genes[J]. Mol Cell Biol, 1991, 11 (10):5032-43. 被引量:1
  • 9Carvajal A, Espinoza N, Kato S, et al. Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75[J].Breast Cancer Res Treat, 2005, 94(2): 171-83. 被引量:1
  • 10Lange CA, Richer JK, Horwitz KB. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals[J]. Mol Endocrinol, 1999, 13(6): 829-36. 被引量:1

共引文献2

同被引文献66

  • 1Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet, 2005, 365 (9476) : 2041-2054. 被引量:1
  • 2Pesta M, Kulda V, Fiala O, et al. Prognostic Significance of ER- CC1,RRM1 and BRCA1 in Surgically-treated Patients with Non- small Cell Lung Cancer. Anticancer Res, 2012, 32 ( 11 ) : 5003-5010. 被引量:1
  • 3Stefansson OA, Villanueva A, Vidal A, et al. BRCA1 epigenetic in- activation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer. Epigeneties, 2012, 7 ( 11 ) : 1225- 1229. 被引量:1
  • 4Leongamornlert D, Mahmud N, Tymrakiewicz M, et al. Germline BRCA1 mutations increase prostate cancer risk. Br J Cancer, 2012, 106(10) : 1697- 1701. 被引量:1
  • 5Wei J, Costa C, Ding Y, et al. mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in ad- vanced gastric cancer. J Natl Cancer Inst, 2011,103 (20) : 1552-1556. 被引量:1
  • 6Mullan PB, Quinn JE, Harkin DP. The role of BRCA1 in transcrip- tional regulation and cell cycle control. Oncogene, 2006,25 (43) : 5854-5863. 被引量:1
  • 7Burga LN,Hu H,Juvekar A,et al. Loss of BRCA1 leads to an in- crease in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCal-mutant mice. Breast Cancer Res, 2011,13(2) : R30. 被引量:1
  • 8Lima ES, Maranhao RC. Rapid, simple laser-light-scattering method for HDL particle sizing in whole plasma. Clin Chem, 2004,50(6) : 1086-1088. 被引量:1
  • 9Holstege H, Joosse SA, van Oostrom CT, et al. High incidence of protein- truncating TP53 mutations in BRCAI- related breast cancer [J]. Cancer Res, 2009,69 (8) :3625-3633. 被引量:1
  • 10LiC, CaoS, Liu Zet, et al. RNAi- mediated downregulation of uPAR synergizes with targeting of HER2 through the ERK pathway in breast cancer cells [J]. Cancer, 2010, 127 (7) : 1507-1516. 被引量:1

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部